Print（PDF/169KB） Feb. 22, 2023 Sustainability

Sumitomo Pharma Announces Contributes to the Relief Efforts for the Earthquake in Turkey and Syria

Sumitomo Pharma Co., Ltd. (Head Office: Osaka, Japan; Representative Director, President and CEO: Hiroshi Nomura) expresses its deepest sympathy for victims of Turkey and Syria by the earthquake-hit in Southeast-Turkey on February 6 2023, and our thoughts are with those personally affected by the tragedy.

Sumitomo Pharma announced today that the Company will donate JPY 5 million through United Nations Children's Fund (UNICEF) to aid relief efforts for victims of the earthquake.